A growing number of reported cases in the United States have led to a concerning measles outbreak. As of January 1, 2025, hospitalization rates stand at 12%, with two confirmed deaths and one death under investigation.
Despite this increasing trend, the risk of measles remains low due to high vaccination coverage and rapid case identification efforts. The MMR vaccine is highly effective in preventing measles and its complications.
In recent months, the Centers for Disease Control and Prevention (CDC) has reported 607 confirmed cases across 22 jurisdictions, with six outbreaks identified. Notably, Texas and New Mexico account for more than 90% of these cases, largely among unvaccinated children and adolescents.
Measles is highly contagious, starting with symptoms like fever, cough, and a runny nose, followed by a characteristic rash. The virus can spread through direct contact or airborne transmission, remaining infectious in the air and on surfaces for up to two hours after an infected person leaves an area.
To manage cases of suspected measles, healthcare facilities should isolate patients immediately and notify public health authorities within 24 hours. Those exposed may be eligible for post-exposure prophylaxis with a vaccine or immunoglobulin.
Medical care for measles primarily involves supportive care, without specific antiviral treatment. Vitamin A supplements are sometimes administered under medical supervision to alleviate symptoms, but overuse can lead to toxicity and damage.
The CDC has issued a health advisory on the ongoing outbreak, emphasizing the need for continued vigilance and guidance for travelers during the upcoming season.
Source: https://www.cdc.gov/measles/hcp/clinical-overview/stay-alert-for-measles-cases.html